The FDA plans to “rapidly make available” rare disease drugs and make use of surrogate endpoints to get promising medicines ...

Vinay Prasad has worked as a professor of medicine ... He steps into the shoes vacated by Peter Marks, who resigned from the role a few weeks ago – reportedly before being pushed out ...

A new, highly transmissible COVID subvariant has been detected in California — heightening the risk of a summer wave as ...

Abeona's ZEVASKYN approval and a $3.1 million price point are undervalued by the market. Find out why ABEO stock is a Buy.

Dr Peter Marks, who has been director of the FDA's Centre for Biologics Evaluation and Research (CBER) since 2016. The abrupt departure of Peter Marks as the director of the FDA's Centre for ...

To celebrate the anniversary, English rock musician Peter Frampton joins "The Buzz." Frampton shares what it was like to record part of that album at the Long Island Arena in Commack, and reflects ...

Peter Marks, director of the FDA's Center for Biologics Evaluation and Research, speaks at the Informa Biotech Showcase during JP Morgan week. One month ago, the FDA approved two gene therapies ...

The Colorado congresswoman’s inflammatory rhetoric has made her a national symbol of the Trumpist far right. She presents a different image closer to home. COVID, guns, anti-Asian violence, and ...

Peter Aitken is a Newsweek Politics Editor based in New York. His focus is domestic U.S. politics, but he has experience covering Foreign Affairs, Business and Technology. Peter joined Newsweek in ...